Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1

Shaw A.T.Solomon B.J.Chiari R.Riely G.J.Besse B.Soo R.A.Kao S.CHIA-CHI LINBauer T.M.Clancy J.S.Thurm H.Martini J.-F.Peltz G.Abbattista A.Li S.Ou S.-H.I.2022-09-152022-09-1520191470-2045https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075141426&doi=10.1016%2fS1470-2045%2819%2930655-2&partnerID=40&md5=85de2eb31eb7479e8444b84816f3561fhttps://scholars.lib.ntu.edu.tw/handle/123456789/620248[SDGs]SDG3Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trialjournal article10.1016/S1470-2045(19)30655-2316691552-s2.0-85075141426